Lula to Launch AIDS Drug Factory in Mozambique

by Rajashri on  October 17, 2008 at 1:19 PM AIDS/HIV News
RSS Email Print This Page Comment
Font : A-A+

A project to make anti-AIDS drugs in Mozambique is being launched by Brazilian President Luiz Inacio Lula da Silva.

Brazil, long considered a model in the fight against AIDS, will invest 23 million dollars to build a factory to produce generic medications, the foreign ministry said.
 Lula to Launch AIDS Drug Factory in Mozambique
Lula to Launch AIDS Drug Factory in Mozambique

Lula will sign the deal launching the project on Friday, with production of drugs expected to begin before the end of 2009.

He is also due to preside over the opening of an office for the Oswaldo Cruz Foundation, known as Fiocruz, which is managing the project.

The factory will be built with Brazilian technology, but the raw materials to produce the drugs will come from India, a ministry spokesman told AFP.

"Brazil plans to invest 23 million US dollars (17 million euros) in four phases in the Maputo factory. About four million dollars has been earmarked for the first stage of the project, and that money will be available by the end of this year," the spokesman said, speaking on condition of anonymity.

The factory will produce eight anti-retroviral drugs. Mozambican technicians will be trained by Farmanguinhos, a Fiocruz laboratory, which is attached to the Brazilian health ministry.

When the two countries signed the deal last month, Brazilian authorities said they planned for the factory to supply drugs across Africa.

According to government figures, Mozambique's HIV prevalence rate among the 16-to-49 age group is estimated at more than 16 percent.

Experts once feared that Brazil could suffer a similarly severe epidemic, but now only 0.61 percent of Brazilians in the same age bracket are infected with AIDS.

Brazil has undertaken aggressive prevention programmes and about one-third of Brazilians living with AIDS receive free treatment.

Source: AFP
RAS/SK

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs AIDS - Initial Theories and Disease Progression 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive